|
1.4 BIOLOGIE - TECHNOS
|
|
|
|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
|
4.2 DÉP., DIAG. & PRONO. - GÉNOME
|
|
|
|
4.3 DÉP., DIAG. & PRONO. - INDUSTRIELS
|
|
|
|
4.7 DÉP., DIAG. & PRONO. - COL DE L'UTÉRUS
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
|
|
Two for the Price of One: Mechanistic Insights Lead to Drug Repositioning [University of Tsukuba]
|
|
|
|
|
|
A new study reported in the journal Clinical Cancer Research has raised hopes in this field by revealing how a cancer-promoting protein called stratifin causes lung adenocarcinoma to emerge. This finding by researchers at University of Tsukuba also enabled the identification of two drugs, currently used for treating other health conditions, which are promising for treating this type of lung cancer.
|
|
|
|
|
|
|
5.12 IMMUNOTHÉRAPIES
|
|
|
|
5.12.3 IMMUNOTHÉRAPIES-COMBINAISONS
|
|
|
|
5.12.6 IMMUNOTHÉRAPIES - AMM
|
|
|
|
|
|
|
|
5.2 PHARMA
|
|
|
|
5.4 TRAITEMENTS - ECONOMIE
|
|
|
|
6.1 OBSERVATION
|
|
|
|
Learning-by-doing in cancer surgery [Healthcare Economist]
|
|
|
|
|
|
Further, the learning-by-doing appears to accrue at the physician rather than organizational level. Following an approach outlined by Levitt et al. (2013), the authors find that clinics with lower turnover have a stronger volume-survival relationship compared to clinics with high physician turnover. In short, for cancer surgeons, practice does make perfect.
|
|
|
|
|
|
|
|
|
6.11 PATIENTS
|
|
|
|
6.2 IMPLANTS MAMMAIRES
|
|
|